World-First Korean Nod For Hanmi's Neutropenia Contender Rolontis

US Pre-Approval Inspection Bodes Well?

 
• By Jung Won Shin
  
neutropenia
Rolontis Becomes First Drug Using Hanmi’s Platform Technology To Be Approved • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia